hypertension
Cardiovascular · 2005–2013
26decisions
20medicines
0carried consumer input
0individual submissions
Every decision here pre-dates the consumer comments facility, so no input would be recorded either way.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| olmesartan medoxomil, amlodipine, hydrochlorothiazide Treatment of hypertension in patients whose blood pressure is not adequately controlled by two of the following: an angiotensin II receptor antagonist, a… | Jul 2013 | Recommended | no section in document |
| telmisartan with amlodipine Hypertension in a patient who is not adequately controlled with either of the drugs in the combination. | Mar 2011 | Recommended with restriction | no section in document |
| aliskiren For the treatment of hypertension. | Jul 2010 | Not recommended | no section in document |
| amlodipine (as besylate) with valsartan and hydrochlorothiazide Hypertension in a patient who is not adequately controlled with any two of the drugs in the combination. | Jul 2010 | Recommended with restriction | no section in document |
| losartan treatment of hypertension | Jul 2010 | Recommended | no section in document |
| olmesartan medoxomil with amlodipine Hypertension in patients who are not adequately controlled with either angiotensin II receptor antagonist or dihydropyridine calcium channel blocker… | Jul 2010 | Recommended with restriction | no section in document |
| aliskiren Treatment of hypertension in patients where an agent acting on the renin-angiotensin system is considered clinically indicated. | Jul 2010 | Not recommended | no section in document |
| amlodipine with valsartan and hydrochlorothiazide Hypertension in patients not adequately controlled with any two of the drugs in the combination. | Jul 2010 | Recommended with restriction | no section in document |
| losartan potassium Treatment of hypertension, alone or in combination with other antihypertensives. Also registered for treatment of hypertensive type 2 diabetics with… | Jul 2010 | Recommended | no section in document |
| olmesartan medoxomil with amlodipine Hypertension in patients who are not adequately controlled with either angiotensin II receptor antagonist or dihydropyridine calcium channel blocker… | Jul 2010 | Recommended with restriction | no section in document |
| perindopril arginine with amlodipine besylate Hypertension in a patient who is not adequately controlled with either of the drugs in the combination. Stable coronary heart disease in a patient who is… | Mar 2010 | Recommended with restriction | no section in document |
| valsartan with hydrochlorothiazide Hypertension in patients who are not adequately controlled with either hydrochlorothiazide or valsartan monotherapy. | Jul 2008 | Recommended with restriction | no section in document |
| amlodipine besylate with valsartan Hypertension in patients who are not adequately controlled with either amlodipine or valsartan monotherapy | Jul 2008 | Recommended with restriction | no section in document |
| lercanidipine with enalapril Hypertension in patients who are not adequately controlled with either lercanidipine or enalapril monotherapy. | Mar 2008 | Recommended with restriction | no section in document |
| olmesartan medoxomil with hydrochlorothiazide Hypertension in patients who are not adequately controlled with either hydrochlorothiazide or olmesartan monotherapy | Mar 2007 | Recommended with restriction | no section in document |
| ramipril with felodipine Hypertension in a patient not adequately controlled with either ramipril or felodipine monotherapy. | Mar 2007 | Recommended with restriction | no section in document |
| ramipril with felodipine Treatment of hypertension in patients not adequately controlled with either ramipril or felodipine monotherapy, or receiving both concomitantly. | Mar 2007 | Recommended with restriction | no section in document |
| amlodipine besylate with atorvastatin calcium Fixed combination for patients with concomitant hypertension and dyslipidaemia, or concomitant angina and dyslipidaemia, meeting criteria set out in the… | Jul 2006 | Recommended with restriction | no section in document |
| moxonidine Treatment of hypertension in patients receiving concurrent antihypertensive therapy. | Mar 2006 | Recommended with restriction | no section in document |
| moxonidine Treatment of hypertension as add-on therapy in patients receiving concurrent antihypertensive therapy, where a centrally acting agent is required. | Mar 2006 | Recommended with restriction | no section in document |
| trandolapril with verapamil hydrochloride-sr Hypertension in a patient who is stabilised on treatment with trandolapril 4 mg and verapamil hydrochloride sustained release 240 mg. | Nov 2006 | Recommended with restriction | no section in document |
| trandolapril with verapamil hydrochloride Treatment of hypertension in patients who are not adequately controlled with 4 mg of trandolapril monotherapy. | Nov 2006 | Recommended with restriction | no section in document |
| olmesartan medoxomil treatment of hypertension | Nov 2005 | Recommended | no section in document |
| trandolapril with verapamil the treatment of hypertension. Treatment should not be initiated with this fixed dose combination. | Nov 2005 | Not recommended | no section in document |
| olmesartan medoxomil Treatment of hypertension. Olmesartan medoxomil is an angiotensin II antagonist for the management of essential hypertension. | Nov 2005 | Recommended | no section in document |
| trandolapril with verapamil hydrochloride Treatment of hypertension. Treatment should not be initiated with this fixed dose combination. | Nov 2005 | Not recommended | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 0 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.